Healthcare Pharmaceutical Biotech

HumeCare+ GLP-1 Reviewed 2026: Pricing, Body Composition Tracking, and What to Verify Before You Enroll

July 8, 2026 8:15 PM

Quick disclosure before you read further: this is a paid advertorial. A commission is earned if you purchase through links in this article, and product claims are attributed to the brand rather than independently endorsed. HumeCare+ connects patients with an independent licensed medical group. Prescription medication, including compounded GLP-1 medication, is not FDA-approved and has not been reviewed by the FDA for safety, effectiveness, or...

Read more

Prosperity Flow Review 2026: Are These Celebrity-Fronted Focus Drops the Daily Mindset Upgrade Buyers Are Rechecking Before Ordering?

July 8, 2026 12:45 PM

Title phrases including "abundance" reflect the brand's own marketing language at getprosperityflow.com. This publication does not independently substantiate them. Readers seeking verification context should continue reading. "Review" in this title refers to this article's own editorial examination of the brand's claims, not any external regulatory or legal action. Quick disclosure before you read further: this is a paid advertorial. A...

Read more

HIV Is Now a Manageable Chronic Condition - How CVS Specialty Helps Patients Start and Stay on Treatment

July 8, 2026 10:30 AM

Originally published on CVS Health Company Newsroom Key points Diagnosed at a time when HIV was often considered a terminal condition, CVS Specialty patient Christopher Hooper is now living a full life decades later, reflecting the impact of modern treatment. Today's HIV therapies can help people manage the condition long term, with effective treatment and prevention options available. CVS Specialty pharmacists, HIV-focused CareTeams and Center...

Read more

Newest Issue of Chairside(R) Magazine Explores the Innovations Reshaping Modern Dentistry

July 8, 2026 10:00 AM

Volume 21, Issue 2 of Chairside® magazine is now available in print and online at chairsidemagazine.com. This special innovations issue features two free CEUs and examines the breakthroughs driving progress in modern dentistry. "Innovation only matters if it solves real problems for practicing dentists," said Jim Glidewell, CDT, founder and president of Glidewell. "This new issue of Chairside magazine highlights the people, research and...

Read more

Dr. Armin Ernst Co-Edits Second Edition of Leading Interventional Pulmonology Textbook

July 8, 2026 9:50 AM

Springer has published the second edition of Principles and Practice of Interventional Pulmonology, a comprehensive medical reference co-edited by Dr. Armin Ernst, an internationally recognized pioneer in the field of interventional pulmonology. The updated text is now available in hardcover and Kindle editions (ISBN 9783031804656). The first edition established itself as an evidence-based resource of choice for interventional pulmonologists...

Read more

Medical Care Technologies Subsidiary Infinite Auctions Surges Past $158,000 in High-Profile Memorabilia Auction with Explosive Viewer Engagement

July 8, 2026 9:11 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted powerful momentum at its wholly-owned subsidiary Infinite Auctions, where the ongoing summer memorabilia auction has already reached $158,478.02 in total value with over 82,500 views and more than two weeks remaining until the July 25 close. The auction features standout iconic items, including a LeBron James record milestone jersey with a current bid of $42,500, a pair of Kobe...

Read more

1upHealth Announces 1up Gateway to Simplify CMS-0057-F Compliance for Health Plans

July 8, 2026 9:03 AM

1upHealth, a leader in health data interoperability, today announced the 1up Gateway, a new model to support compliance with the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) among health plans with existing FHIR infrastructure. With this new release, 1upHealth is ensuring the broader payer ecosystem is prepared for interoperability regulations ahead of the final January 1, 2027 deadline. As plans adapt to CMS-0057-F...

Read more

Alpha Genesis Adds Rodent Studies, Creating an Integrated Rodent-to-Primate Preclinical Platform

July 8, 2026 9:00 AM

Alpha Genesis, Inc. (AGI), an AAALAC-accredited and USDA-licensed preclinical research organization, today announced the availability of rodent research services for GLP and non-GLP programs, extending one of the industry's most established nonhuman-primate research operations into small-animal preclinical development. With the addition of rodent studies, Alpha Genesis now offers sponsors a more integrated path from early proof-of-concept,...

Read more

Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily

July 8, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, reports that a Coverage Initiating Research Report on the Company by an Independent Analyst has been published, dated as of July 6, 2026. The report rates the Company with a rating of "Outperform" and has assigned a target price of $6.00, based on the analyst's estimates. This research report provides a summary...

Read more

BartletLab to Distribute US-Grown Hemp Products Nationally

July 8, 2026 8:15 AM

BartletLab, a world-class marketer and distributor of dietary supplements, has begun distributing US-grown natural hemp products to select states. "Our goal is to provide the highest quality natural hemp products to our health-conscious customers," says BartletLab's director of marketing. "Our customers appreciate that our products are made in the USA to GMP Certified standards." Whether customers prefer to discover new products the "old-school"...

Read more

The Blueprint for Better Lung Cancer Screening

July 8, 2026 7:29 AM

Kentucky has the highest lung cancer rates in the U.S., but it's also becoming a model for how to fight back. Experts behind the QUILS™ system join Devex to discuss early detection, coalition building, and lessons applicable to health systems worldwide. In this special edition of the This Week in Global Development podcast, produced in partnership with the Bristol Myers Squibb Foundation, Devex cofounder and Executive Vice President Alan Robbins...

Read more

Moderna Appoints Michael McDonnell to Board of Directors

July 8, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced the appointment of Michael McDonnell to its Board of Directors, effective July 8, 2026. Mr. McDonnell will also serve on the Board's Audit Committee. "Mike brings exceptional financial leadership and strategic perspective developed over more than three decades advising and leading global life sciences and technology companies," said Noubar Afeyan, Ph.D., Co-Founder and Chairman of Moderna. "His...

Read more

Who Does the Best Nose Job in Florida?

July 8, 2026 6:00 AM

Rhinoplasty, commonly known as a nose job, remains one of the most demanding procedures in facial cosmetic surgery. Unlike many aesthetic surgeries, rhinoplasty requires surgeons to improve the appearance of the nose while maintaining its structural integrity and, when necessary, preserving or restoring normal breathing. As demand for facial cosmetic surgery continues to grow across Florida, patients are increasingly evaluating surgeons based on...

Read more

How Much Does Laser Hair Removal Cost in Seattle?

July 8, 2026 6:00 AM

The price of laser hair removal in Seattle can vary significantly depending on the treatment area, the number of sessions included, the technology used, and the experience of the provider. While many practices charge by the session, Seattle Plastic Surgery has introduced packages beginning at $99 for four laser hair removal sessions, making it one of the most affordable options available for patients seeking long-term hair removal. Why Laser...

Read more

Seattle's Best Plastic Surgeon Featured in Seattle Magazine and Seattle Met

July 8, 2026 6:00 AM

As patients increasingly rely on independent media, physician credentials, and published expertise when researching plastic surgery, regional publications are playing a larger role in highlighting surgeons whose work extends beyond the operating room. Recent articles published by Seattle Magazine and Seattle Met feature Dr. Javad Sajan, emphasizing not only his surgical experience but also his innovative techniques and patient-first philosophy....

Read more

Black Book Poll Finds AI Has Entered the EHR, but Governed Scale Remains the Missing Link

July 7, 2026 4:55 PM

Black Book Research today released findings from its AI in the EHR Adoption Readiness Poll, a 507-respondent assessment of healthcare executives, informatics leaders and clinical operations respondents fielded in Q2-Q3 2026. The poll finds that AI has moved from strategic conversation into active EHR workflows, but most healthcare organizations have not yet built the operating model required to scale it safely, consistently and measurably. The...

Read more

Lower-Cost Generic Ozempic (Semaglutide) Is Now Available From Canada for U.S. Patients

July 7, 2026 3:00 PM

Generic Ozempic (semaglutide) is now available from Canada at just $199.99/month, as prices for this medication in the U.S. still remain more than $1,000 for many patients without coverage. Credited Pharmacy helps U.S. patients locate reliable Canadian prescription fulfillment services with the aim of helping patients in the US obtain more affordable prescription care from Canada. Patients can use Credited Pharmacy to find safe and reliable...

Read more

DEA Scientist Testifies Against DEA's Own Rescheduling Posture In Court

July 7, 2026 1:35 PM

On day six of the Drug Enforcement Administration's marijuana rescheduling hearing, the agency's own scientist delivered testimony that cuts against the very rule the hearing is meant to advance. Dr. Luli Akinfiresoye - a pharmacologist in the DEA's Drug and Chemical Evaluation Section who holds a Ph.D. in pharmacology from Howard University, and who authored the DEA's 2024 Scientific Data Review of marijuana - testified that marijuana does not...

Read more

TRNR Signs Definitive Agreement to Acquire STEPR, Raises 2026 Pro Forma Revenue Guidance to More Than $50m

July 7, 2026 9:45 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), owner of the Wattbike, CLMBR, FORME, and Ergatta connected fitness brands, today announced it has signed a definitive agreement to acquire STEPR, Inc. ("STEPR"), a category leader in connected stair climbing for home and commercial training. STEPR is a hardware-first fitness company that has built the leading position in connected stair climbing, profitably and bootstrapped with...

Read more

Medical Care Technologies, Inc. (OTC Pink:MDCE) Details Six-Phase Internal Testing Protocol Driving Melanoma Scan Beta Progress

July 7, 2026 9:17 AM

Medical Care Technologies, Inc. (OTC PINK:MDCE) today elaborated on the rigorous six-phase internal testing framework that has powered the encouraging results announced on June 26, 2026. Following the initial structured testing announcement on June 12, 2026, the Company has implemented a comprehensive, multi-stage internal evaluation process focused on training and optimizing its proprietary AI vision models for the MDCE Melanoma Scan Beta...

Read more